Oracle Investment Management Inc has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $43.2 Million distributed in 22 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Phathom Pharmaceuticals, Inc. with a value of $13.6M, Ardelyx, Inc. with a value of $9.43M, Quidel Ortho Corp with a value of $5.39M, Biocryst Pharmaceuticals Inc with a value of $4.07M, and Myriad Genetics Inc with a value of $3.68M.

Examining the 13F form we can see an increase of $5.23M in the current position value, from $38M to 43.2M.

Oracle Investment Management Inc is based out at Greenwich, CT

Below you can find more details about Oracle Investment Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $43.2 Million
Healthcare: $42.2 Million
Technology: $1.02 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 22
  • Current Value $43.2 Million
  • Prior Value $38 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.